PDUFA III “Good Review Management Principles” Stress Early FDA Action
This article was originally published in The Tan Sheet
Executive Summary
FDA's "Good Review Management Principles" guidance will recognize the need to complete second- and third-round reviews of NDAs before the action goal date under the Prescription Drug User Fee Act III